EUVIMEDEUVIMED entdecken
Open Access · CC BY-SA 4.0

CLINICAL APPLICATION OF PROBIOTICS IN INTENSIVE CARE UNIT (ICU)

Ruth Aritonang, Agustina Br Haloho

Indonesian Journal of Anesthesiology and Critical Care Medicine · 2026

DOI: 10.64531/ssz6ca94 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Indonesian Journal of Anesthesiology and Critical Care Medicine, 2026. Verfasst von Ruth Aritonang und 1 weiteren Autor:innen. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-SA 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The gut microbiome comprises a complex community of bacteria that collectively perform various essential functions in the human body. A balanced gut microbiome enhances the host’s defense against infections through mechanisms such as modulation of the local and systemic immune systems, suppression of enteric pathogens, and support of intestinal epithelial barrier integrity. Conversely, an imbalance in the microbiome, known as dysbiosis, has been shown to negatively impact the host and is associated with a variety of disease conditions. This is particularly relevant in the intensive care unit (ICU) setting, where critically ill patients—such as those with respiratory failure, sepsis, myocardial infarction, cardiovascular procedures, intracerebral hemorrhage, and cerebral infarction—experience ongoing disruptions of their microbiome due to both the underlying disease and iatrogenic effects of clinical interventions. Probiotics are live, non-pathogenic microorganisms, primarily bacteria, yeasts, or fungi, that confer health benefits to the human body, especially the digestive system. Broad-spectrum antibiotic use, acute dietary changes, and disease-induced stress can all disrupt the gut microbiome’s homeostasis in patients. As a result, nearly all ICU patients experience severe disruption of the gut microbiome. Case reports discussed in this article show that probiotics may reduce the incidence of ventilator-associated pneumonia (VAP), the duration of mechanical ventilation, ICU length of stay, and hospital mortality.

Zitieren

APA

Aritonang, R., & Haloho, A. B. (2026). CLINICAL APPLICATION OF PROBIOTICS IN INTENSIVE CARE UNIT (ICU). Indonesian Journal of Anesthesiology and Critical Care Medicine. https://doi.org/10.64531/ssz6ca94

Vancouver

Aritonang R, Haloho AB. CLINICAL APPLICATION OF PROBIOTICS IN INTENSIVE CARE UNIT (ICU). Indonesian Journal of Anesthesiology and Critical Care Medicine. 2026. doi:10.64531/ssz6ca94

BibTeX
@article{Aritonang2026,
  author = {Aritonang, Ruth and Haloho, Agustina Br},
  title = {CLINICAL APPLICATION OF PROBIOTICS IN INTENSIVE CARE UNIT (ICU)},
  journal = {Indonesian Journal of Anesthesiology and Critical Care Medicine},
  year = {2026},
  doi = {10.64531/ssz6ca94}
}
Kostenlos starten →